Clinical studies have shown that patients with Zswim6 genetic mutations are associated with developmental and neurological diseases, including schizophrenia, acromelic frontonasal dysostosis and intellectual disability (Ripke et al., 2013; Lencz et al., 2014; Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014; Smith et al., 2014; Twigg et al., 2016; Palmer et al., 2017). The gene discussed is ZSWIM6; the disease is schizophrenia.